Vyant Bio, Inc.
VYNT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$22,690 | -$40,859 | -$8,650 | -$6,708 |
| Dep. & Amort. | $843 | $1,054 | $1,110 | $757 |
| Deferred Tax | $0 | -$465 | -$208 | $0 |
| Stock-Based Comp. | $1,186 | $1,003 | $372 | $0 |
| Change in WC | $891 | -$2,687 | $1,329 | $18,152 |
| Other Non-Cash | $6,089 | $24,961 | $235 | -$21,124 |
| Operating Cash Flow | -$13,681 | -$16,993 | -$5,812 | -$8,660 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$617 | -$535 | -$60 | -$28 |
| Net Acquisitions | $0 | $30,163 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $3,880 | -$9 | $17 | $9,119 |
| Investing Cash Flow | $3,263 | $29,619 | -$43 | $9,091 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$188 | $41 | $1,348 | $5,412 |
| Stock Repurch. | -$188 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$149 | $7,190 | $6,332 | $3,305 |
| Financing Cash Flow | -$149 | $7,190 | $6,332 | $3,305 |
| Forex Effect | $0 | $0 | -$68 | -$17 |
| Net Chg. in Cash | -$10,567 | $19,816 | $477 | $3,719 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20,608 | $792 | $315 | $511 |
| End Cash | $10,041 | $20,608 | $792 | $4,230 |
| Free Cash Flow | -$14,298 | -$17,528 | -$5,872 | -$8,688 |